Macrophage accumulation and renal fibrosis are independent of macrophage migration inhibitory factor in mouse obstructive nephropathy

Nephrology

Volumn 9, Issue 5, 2004, Pages 278-287

  Rice, Edwina K ^a   Nikolic Paterson, David J ^a   David, John R ^b   Bucala, Richard ^c   Metz, Christine N ^d   Atkins, Robert C ^a   Tesch, Gregory H ^a,e  

^a MONASH UNIVERSITY   (Australia)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d N Shore Long Isl Jewish Res Inst ^*  (United States)

^e MONASH MEDICAL CENTRE   (Australia)

Author keywords

Fibrosis; Kidney; Leucocytes; Macrophage migration inhibitory factor; Obstructive nephropathy

Indexed keywords

CHEMOKINE; COLLAGEN; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; OSTEOPONTIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE COURSE; FIBROBLAST; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY INTERSTITIUM; LEUKOCYTE ACTIVATION; MACROPHAGE; MOUSE; NONHUMAN; NORTHERN BLOTTING; OBSTRUCTIVE NEPHROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; URETER LIGATION; WILD TYPE;

ANIMALS; FIBROSIS; KIDNEY; KIDNEY DISEASES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MACROPHAGES; MICE; MICE, INBRED C57BL; URETERAL OBSTRUCTION;

EID: 9644287888     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2004.00319.x     Document Type: Article

References (39)

1. Calandra T, Bernhagen J, Mitchell RA et al. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J. Exp. Med. 1994; 179: 1895-902.
2. David JR. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl Acad. Sci. USA 1966; 56: 72-7.
3. Bloom BR, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966; 153: 80-2.
4. Bernhagen J, Calandra T, Mitchell RA et al. MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 1993; 365: 756-9.
5. Bacher M, Metz CN, Calandra T et al. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl Acad. Sci. USA 1996; 93: 7849-54.
6. Wistow GJ, Shaughnessy MP, Lee DC et al. A macrophage migration inhibitory factor is expressed in the differentiating cells of the eye lens. Proc. Natl Acad. Sci. USA 1993; 90: 1272-1275, 1993.
7. Chesney J, Metz C, Bacher M et al. An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol. Med. 1999; 5: 181-91.
8. Rosengren E, Bucala R, Aman P et al. The immunoregulatory mediator macrophage migration inhibitory factor (MIF) catalyzes a tautomerization reaction. Mol. Med. 1996; 2: 143-9.
9. Rosengren E, Aman P, Thelin S et al. The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase. FEBS Lett. 1997; 417: 85-8.
10. Kleemann R, Kapurniotu A, Frank RW et al. Disulfide analysis reveals a role for macrophage migration inhibitory factor (MIF) as thiol-protein oxidoreductase. J. Mol. Biol. 1998; 280: 85-102.
11. Benigni F, Atsumi T, Calandra T et al. The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle. J. Clin. Invest. 2000; 106: 1291-300.
12. Waeber G, Calandra T, Roduit R et al. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor. Proc. Natl Acad. Sci. USA 1997; 94: 4782-7.
13. Calandra T, Bernhagen J, Metz CN et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995; 377: 68-71.
14. Lan HY, Mu W, Yang N et al. De novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am. J. Pathol. 1996; 149: 1119-27.
15. Tesch GH, Nikolic-Paterson DJ, Metz CN et al. Rat mesangial cells express macrophage migration inhibitory factor in vitro and in vivo. J. Am. Soc. Nephrol. 1998; 9: 417-24.
16. Kim YG, Huang XR, Suga S et al. Involvement of macrophage migration inhibitory factor (MIF) in experimental uric acid nephropathy. Mol. Med. 2000; 6: 837-48.
17. Song Q, Nikolic-Paterson DJ, Atkins RC et al. Delayed-type hypersensitivity mediates Bowman's capsule rupture in Tamm-Horsfall protein-induced tubulointerstitial nephritis in the rat. Nephrology 1996; 2: 417-27.
18. Lan HY, Bacher M, Yang N et al. The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J. Exp. Med. 1997; 185: 1455-65.
19. Yang N, Nikolic-Paterson DJ, Ng YY et al. Reversal of established rat crescentic glomerulonephritis by blockade of macrophage migration inhibitory factor (MIF): Potential role of MIF in regulating glucocorticoid production. Mol. Med. 1998; 4: 413-24.
20. Klahr S. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am. J. Kidney Dis. 1991; 18: 689-99.
21. Schreiner GF, Harris KP, Purkerson ML et al. Immunological aspects of acute ureteral obstruction: Immune cell infiltrate in the kidney. Kidney Int. 1988; 34: 487-93.
22. Rovin BH, Harris KP, Morrison A et al. Renal cortical release of a specific macrophage chemoattractant in response to ureteral obstruction. Lab. Invest. 1990; 63: 213-20.
23. Bozza M, Satoskar AR, Lin G et al. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 1999; 189: 341-6.
24. Lan HY, Mu W, Nikolic-Paterson DJ et al. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: Use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J. Histochem. Cytochem. 1995; 43: 97-102.
25. Sharma AK, Mauer SM, Kim Y et al. Interstitial fibrosis in obstructive nephropathy. Kidney Int. 1993; 44: 774-88.
26. Van Goor H, Ding G, Kees-Folts D et al. Macrophages and renal disease. Lab. Invest. 1994; 71: 456-64.
27. Lan HY, Yang N, Brown FG et al. Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 1998; 66: 1465-71.
28. Lan HY, Yang N, Nikolic-Paterson DJ et al. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int. 2000; 57: 499-509.
29. Klahr S. Urinary tract obstruction. Semin. Nephrol. 2001; 21: 133-45.
30. Diamond JR, Kees-Folts D, Ricardo SD et al. Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am. J. Pathol. 1995; 146: 1455-66.
31. Diamond JR, Kees-Folts D, Ding G et al. Macrophages, monocyte chemoattractant peptide-1, and TGF-beta 1 in experimental hydronephrosis. Am. J. Physiol. 1994; 266: F926-33.
32. Ricardo SD, Levinson ME, DeJoseph MR et al. Expression of adhesion molecules in rat renal cortex during experimental hydronephrosis. Kidney Int. 1996; 50: 2002-10.
33. Vielhauer V, Anders HJ, Mack M et al. Obstructive nephropathy in the mouse: Progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J. Am. Soc. Nephrol. 2001; 12: 1173-87.
34. Isbel NM, Hill PA, Foti R et al. Tubules are the major site of M-CSF production in experimental kidney disease: Correlation with local macrophage proliferation. Kidney Int. 2001; 60: 614-25.
35. Ophascharoensuk V, Giachelli CM, Gordon K et al. Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int. 1999; 56: 571-80.
36. Anders HJ, Vielhauer V, Frink M et al. A chemokine receptor CCR-1 antagonist reduces renal fibrosis after unilateral ureter ligation. J. Clin. Invest. 2002; 109: 251-9.
37. Cheng QL, Chen XM, Li F et al. Effects of ICAM-1 antisense oligonucleotide on the tubulointerstitium in mice with unilateral ureteral obstruction. Kidney Int. 2000; 57: 183-90.
38. Le Meur Y, Tesch GH, Hill PA et al. Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J. Leuk. Biol. 2002; 72: 530-7.
39. Mitchell RA, Metz CN, Peng T et al. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF). Regulatory role in cell proliferation and glucocorticoid action. J. Biol. Chem. 1999; 274: 18 100-6.